18
Thu, Apr
38 New Articles

BASEAK and Akol Ozok Namli Advise on Pera Capital Acquisition of Shares in Asset Medikal

BASEAK and Akol Ozok Namli Advise on Pera Capital Acquisition of Shares in Asset Medikal

Turkiye
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

Balcioglu Selcuk Akman Keki Attorney Partnership has succesfully advised Pera Capital on its acquisition of 45% of the shares of Asset Medikal from the Teknoloji Yatirim A.S. venture capital firm and founding Asset Medikal shareholders Mehmet Tuysuz, Fusun Tuysuz, and Filiz Bayindir. The Akol Ozok Namli Attorney Partnership advised Teknoloji Yatirim and the Yasaman Law Firm advised the shareholders.

According to BASEAK, the transaction marks the first time shares held by a venture capital fund have been acquired by a private equity fund.

Asset Medikal is a needle-free injection valves manufacturer that has partnered with Teknoloji Yatirim A.S., an early-stage venture capital firm and a subsidiary of the Technology Development Foundation of Turkey.

Pera Capital is an independent, private equity fund focusing on mid-sized enterprises in Turkey. Pera Capital's corporate investors include the EBRD, European Investment Funds, Caisse des Depots, Sarona Asset Management, and various European family investment offices.

BASEAK's team included Senior Partner Dogan Eymirlioglu, Senior Associate Duygu Cetinkaya, and Associate Cenk Yilgor.

Unlu & Co. provided financial advice on the deal. The Akol Law Firm team advising both Unlu & Co. and Teknoloji Yatirimour was led by Partner Meltem Akol, supported by Senior Associate Zeynep Sener and Associates Kaan Demir and Begum Kayum. 

The Yasaman Law Firm did not reply to our inquiry.